4.5 quarters of funding remaining and we expect FDA approval in 2025 before our reserves dip below 2 quarters.
We probably won't need to do another CR but, even if we do, it would be after FDA approval and at a much higher SP, well north of $2.
Ann: Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
-0.030(1.97%) |
Mkt cap ! $477.4M | |||
| Open | High | Low | Value | Volume |
| $1.52 | $1.52 | $1.48 | $273.2K | 181.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 937 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.50 | 5156 | 4 |
View Market Depth
| Last trade - 14.29pm 18/06/2025 (20 minute delay) ? |
| IMR (ASX) Chart |